Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties

Journal of Virology

Volumn 87, Issue 22, 2013, Pages 12158-12165

  Hufbauer, Martin ^a   Biddle, Adrian ^b   Borgogna, Cinzia ^c   Gariglio, Marisa ^c   Doorbar, John ^d   Storey, Alan ^e   Pfister, Herbert ^a   Mackenzie, Ian ^b   Akgül, Baki ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Azienda Ospedaliero Universitaria Maggiore della Carità   (Italy)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN B; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; CD44 PROTEIN, HUMAN; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; MESSENGER RNA; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 8; ONCOPROTEIN; TUMOR ANTIGEN;

ARTICLE; BETAPAPILLOMAVIRUS; BIOACCUMULATION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DNA DAMAGE; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KERATINOCYTE; MORPHOLOGY; NONHUMAN; ONCOGENE; ONCOGENE E2; ONCOGENE E6; ONCOGENE E7; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; APOPTOSIS; CELL PROLIFERATION; CFU COUNTING; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DISEASE; STEM CELL; VIROLOGY; WESTERN BLOTTING;

BETAPAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

ANTIGENS, CD44; ANTIGENS, NEOPLASM; APOPTOSIS; BETAPAPILLOMAVIRUS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN DISEASES; STEM CELLS;

EID: 84886264702     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01510-13     Document Type: Article

References (56)

1. zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.
2. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. 2006. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J. Clin. Microbiol. 44:1755-1762.
3. Cullen AP, Reid R, Campion M, Lorincz AT. 1991. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:606-612.
4. Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, von Knebel Doeberitz M. 2003. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 22:3977-3984.
5. Weissenborn SJ, De Koning MN, Wieland U, Quint WG, Pfister HJ. 2009. Intrafamilial transmission and family-specific spectra of cutaneous betapapillomaviruses. J. Virol. 83:811-816.
6. Dell'Oste V, Azzimonti B, De Andrea M, Mondini M, Zavattaro E, Leigheb G, Weissenborn SJ, Pfister H, Michael KM, Waterboer T, Pawlita M, Amantea A, Landolfo S, Gariglio M. 2009. High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J. Invest. Dermatol. 129:1026-1034.
7. Nindl I, Gottschling M, Stockfleth E. 2007. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis. Markers 23:247-259.
8. Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J, Majewski S, Pfister H, Wieland U. 2005. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J. Invest. Dermatol. 125:93-97.
9. Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. 1997. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J. Invest. Dermatol. 108:712-715.
10. Schmitt A, Rochat A, Zeltner R, Borenstein L, Barrandon Y, Wettstein FO, Iftner T. 1996. The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J. Virol. 70: 1912-1922.
11. Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
12. Bonnet D, Dick JE. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3:730-737.
13. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. 2006. Cancer stem cells- perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66:9339-9344.
14. Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
15. Abbott DE, Postovit LM, Seftor EA, Margaryan NV, Seftor RE, Hendrix MJ. 2007. Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets. Stem Cell Rev. 3:68-78.
16. Foijer F, te Riele H. 2006. Check, double check: the G2 barrier to cancer. Cell Cycle 5:831-836.
17. Bissell MJ, Labarge MA. 2005. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7:17-23.
18. Diehn M, Cho RW, Clarke MF. 2009. Therapeutic implications of the cancer stem cell hypothesis. Semin. Radiat. Oncol. 19:78-86.
19. Huang EH, Heidt DG, Li CW, Simeone DM. 2007. Cancer stem cells: a new paradigm for understanding tumor progression and therapeutic resistance. Surgery 141:415-419.
20. Fillmore CM, Kuperwasser C. 2008. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 10:R25. doi:10.1186/bcr1982.
21. Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC. 2007. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J. Oral Pathol. Med. 36:594-603.
22. Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG. 2008. PC3 human prostate carcinoma cell holoclones contain self-renewing tumorinitiating cells. Cancer Res. 68:1820-1825.
23. Locke M, Heywood M, Fawell S, Mackenzie IC. 2005. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 65:8944-8950.
24. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. 2006. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25:1696-1708.
25. Daley GQ. 2004. Chronic myeloid leukemia: proving ground for cancer stem cells. Cell 119:314-316.
26. Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, Liu Q, Pei D, Kang T, Zeng YX. 2010. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J. Biol. Chem. 285:4931-4940.
27. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:3983-3988.
28. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U. S. A. 104:10158-10163.
29. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. 2007. Identification of pancreatic cancer stem cells. Cancer Res. 67:1030-1037.
30. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. 2007. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 104:973-978.
31. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, Costea DE, Mackenzie IC. 2011. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 71:5317-5326.
32. Shigeishi H, Biddle A, Gammon L, Emich H, Rodini CO, Gemenetzidis E, Fazil B, Sugiyama M, Kamata N, Mackenzie IC. 7 May 2013. Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3beta influenced by CD44 and RHAMM. Stem Cells. doi:10.1002/stem.1418.
33. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. 2004. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23:5748-5758.
34. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ, Gillanders WE. 2004. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 64:5818-5824.
35. Gonzalez B, Denzel S, Mack B, Conrad M, Gires O. 2009. EpCAM is involved in maintenance of the murine embryonic stem cell phenotype. Stem Cells 27:1782-1791.
36. Lu TY, Lu RM, Liao MY, Yu J, Chung CH, Kao CF, Wu HC. 2010. Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells. J. Biol. Chem. 285:8719-8732.
37. Ng VY, Ang SN, Chan JX, Choo AB. 2010. Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells. Stem Cells 28:29-35.
38. Proby CM, Purdie KJ, Sexton CJ, Purkis P, Navsaria HA, Stables JN, Leigh IM. 2000. Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis. Exp. Dermatol. 9:104-117.
39. Akgül B, Bauer B, Zigrino P, Storey A, Mauch C, Pfister H. 2011. Upregulation of lipocalin-2 in human papillomavirus-positive keratinocytes and cutaneous squamous cell carcinomas. J. Gen. Virol. 92:395-401.
40. Westphal K, Akgül B, Storey A, Nindl I. 2009. Cutaneous human papillomavirus E7 type-specific effects on differentiation and proliferation of organotypic skin cultures. Cell Oncol. 31:213-226.
41. Borgogna C, Zavattaro E, De Andrea M, Griffin HM, Dell'Oste V, Azzimonti B, Landini MM, Peh WL, Pfister H, Doorbar J, Landolfo S, Gariglio M. 2012. Characterization of beta papillomavirus E4 expression in tumours from epidermodysplasia verruciformis patients and in experimental models. Virology 423:195-204.
42. Landini MM, Zavattaro E, Borgogna C, Azzimonti B, De Andrea M, Colombo E, Marenco F, Amantea A, Landolfo S, Gariglio M. 2012. Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene. J. Invest. Dermatol. 132:1305-1308.
43. O'Shaughnessy RF, Akgul B, Storey A, Pfister H, Harwood CA, Byrne C. 2007. Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors. Cancer Res. 67:8207-8215.
44. Leverrier S, Bergamaschi D, Ghali L, Ola A, Warnes G, Akgül B, Blight K, Garcia-Escudero R, Penna A, Eddaoudi A, Storey A. 2007. Role of HPV E6 proteins in preventing UVB-induced release of pro-apoptotic factors from the mitochondria. Apoptosis 12:549-560.
45. Akgül B, Garcia-Escudero R, Ghali L, Pfister HJ, Fuchs PG, Navsaria H, Storey A. 2005. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res. 65:2216-2223.
46. Hufbauer M, Lazic D, Akgül B, Brandsma JL, Pfister H, Weissenborn SJ. 2010. Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice. Virology 403: 128-136.
47. Lazic D, Alborzi F, Marcuzzi GP, Angel P, Hess J, Pfister H, Akgül B. 2011. Enhanced StefinA and Sprr2 expression during papilloma formation in HPV8 transgenic mice. J. Dermatol. Sci. 62:84-90.
48. Akgül B, Bostanci N, Westphal K, Nindl I, Navsaria H, Storey A, Pfister H. 2010. Human papillomavirus 5 and 8 E6 downregulate interleukin-8 secretion in primary human keratinocytes. J. Gen. Virol. 91:888-892.
49. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. 2008. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
50. Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z. 2011. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol. 11:71. doi:10.1186/1471-230X-11-71.
51. Visvader JE, Lindeman GJ. 2008. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer. 8:755-768.
52. Sengupta A, Cancelas JA. 2010. Cancer stem cells: a stride towards cancer cure? J. Cell Physiol. 225:7-14.
53. Wray H, Mackenzie IC, Storey A, Navsaria H. 2012. alpha6 integrin and CD44 enrich for a primary keratinocyte population that displays resistance to UV-induced apoptosis. PLoS One 7:e46968. doi:10.1371/journal.pone.0046968.
54. Akgül B, Ghali L, Davies D, Pfister H, Leigh IM, Storey A. 2007. HPV8 early genes modulate differentiation and cell cycle of primary human adult keratinocytes. Exp. Dermatol. 16:590-599.
55. Haller K, Stubenrauch F, Pfister H. 1995. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology 214:245-255.
56. Akgül B, Cooke JC, Storey A. 2006. HPV-associated skin disease. J. Pathol. 208:165-175.